Results 201 to 210 of about 2,816 (233)

In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Marion de Jong, Erik de Blois, Marijke De Saint-Hubert   +2 more
exaly  

In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177

Applied Radiation and Isotopes, 2022
Cristian Antonio Wieczorek Villas Boas, Luiza Balieiro, Bianca Vivaldini   +2 more
exaly  

Lutetium-177 PSMA therapy

Reactions Weekly, 2019
openaire   +1 more source

Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications

Chemical Reviews, 2015
Sharmila Banerjee
exaly  

Analysis of lutetium-177 production at the WWR-K research reactor

Applied Radiation and Isotopes, 2021
exaly  

Gastroenteropancreatic Neuroendocrine Tumors

Ca-A Cancer Journal for Clinicians, 2018
Mauro Cives, Jonathan Strosberg
exaly  

Organ distribution studies of lutetium-177 in mouse

International Journal of Nuclear Medicine and Biology, 1978
W A, Müller, U, Linzner, E H, Schäffer
openaire   +2 more sources

Lutetium-177-rhPSMA10.1

Reactions Weekly
openaire   +1 more source

Chemoradiation therapy using cyclopamine-loaded liquid–lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles

Journal of Controlled Release, 2015
Chunhui Wu, Fada Guan, Dong Liang
exaly  

Lutetium Lu 177 Vipivotide Tetraxetan: First Approval

Molecular Diagnosis and Therapy, 2022
exaly